|
|
Article: EISAI TO RESUME TESTING DRUG FOR ACUTE CORONARY SYNDROME.
- Article from:
- AsiaPulse News
- Article date:
- June 6, 2007
CopyrightCOPYRIGHT 2007 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TOKYO, June 6 Asia Pulse - Eisai Co. (TSE:4523) will resume clinical trials in the U.S. and Europe of its drug for treating acute coronary syndrome.
If all goes as planned, the Japanese company expects to complete the testing as early as 2008 and apply for marketing approval in fiscal year 2011, hoping to release the treatment the same year.
The drug, code-named E5555, works on a protein in the walls of blood vessels to prevent blood clots from forming. It is being developed as a way to reduce the ...